Business / Finance RSS Feed - Business / Finance

Neuland Labs' revenues for third quarter of FY 2015 decrease 17% to $17.14 million

Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and custom manufacturing solutions services to customers located in 85 countries, today announced financial results for the third quarter of fiscal year (FY) 2015, ended December 31, 2014. [More]
Centura Health, DaVita HealthCare Partners jointly unveil FullWell

Centura Health, DaVita HealthCare Partners jointly unveil FullWell

Centura Health and DaVita HealthCare Partners today unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas. [More]

TxCell receives milestone payment of EUR 1 million concerning Ovasave collaboration, license agreement from Trizell

TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA). [More]
Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen. [More]
EKF Molecular Diagnostics collaborates with ANGLE for liquid biopsy development using Parsortix and PointMan technologies

EKF Molecular Diagnostics collaborates with ANGLE for liquid biopsy development using Parsortix and PointMan technologies

EKF Molecular Diagnostics has agreed a collaboration with specialist medtech company ANGLE plc, to investigate the combination of ANGLE's Parsortix circulating tumour cell (CTC) harvesting platform with EKF Molecular's PointMan™ DNA enrichment technology as a liquid biopsy. If successful, the resulting simple blood test could enable the investigation of unexpected ultra-low level mutations in a patient's cancer for personalised cancer care. [More]
Park Systems announces innovations in bio cell analysis with the launch of Park NX-Bio

Park Systems announces innovations in bio cell analysis with the launch of Park NX-Bio

Park Systems, a leading manufacturer of atomic force microscopy (AFM) and nanoscale metrology products, proudly introduces Park NX-Bio, a powerful 3-in-1 bio-research tool that uniquely combines scanning ion conductance microscopy (SICM) with AFM and an inverted optical microscope (IOM) on the same platform. [More]
Marie Csete appointed president and chief scientist of HMRI

Marie Csete appointed president and chief scientist of HMRI

Huntington Medical Research Institutes, a leading biomedical research organization, has announced the appointment of Marie Csete, MD, PhD, its chief scientific officer, to her new role as president and chief scientist of HMRI. [More]
Genevac's new SampleGenie 4 for direct concentration of large sample volumes into vials

Genevac's new SampleGenie 4 for direct concentration of large sample volumes into vials

SampleGenie 4 is the latest version of Genevac’s unique technology for direct concentration of large sample volumes into vials, designed for use in the Rocket Synergy Evaporator. [More]

Biolin Scientific acquires the key patent protecting multi-hole, high-throughput ion channel screening

Biolin Scientific today announces the acquisition of a key patent related to performing multi-hole, high-throughput ion channel screening. [More]

genae announces acquisition of e-novex

genae, a global Contract Research Organization and services provider for the medical industries, announced today the acquisition of e-novex, a leading provider of electronic data tools that change medical research. [More]
Raiing Medical, Boston Children's Hospital sign license agreement for Thermia education platform

Raiing Medical, Boston Children's Hospital sign license agreement for Thermia education platform

Raiing Medical Inc. and Boston Children's Hospital entered a license agreement for Boston Children's Thermia education platform, designed to assist parents in learning more about fever, illness and fever management. The online educational framework will be integrated with Raiing's iThermonitor device, a wearable thermometer with US FDA 510(k) clearance. [More]
University of Colorado, Mile High Ophthalmics sign licensing agreement for new cataract surgery device

University of Colorado, Mile High Ophthalmics sign licensing agreement for new cataract surgery device

A new device designed to perform safer, more effective cataract surgery is going on the market following a licensing agreement between the University of Colorado and Mile High Ophthalmics LLC. [More]

SP Industries acquires privately held Stability Environments

SP Industries, Inc. (SP), a leading designer and manufacturer of state-of-the-art laboratory equipment, biological drug manufacturing solutions, laboratory supplies and specialty glassware, announced today that it has acquired privately held Stability Environments, Inc. a global provider of Walk-in Environmental Rooms, Glassware Dryers, Chambers and accessory products. [More]
Innovent Biologics raises $100 million in Series C financing

Innovent Biologics raises $100 million in Series C financing

Innovent Biologics, Inc., a privately held Chinese biopharmaceutical company dedicated to the development and manufacturing of complex, high-end biologics to be marketed in the rapidly growing Chinese market and elsewhere worldwide that meet EMEA and FDA/cGMP standards, has raised $100 million in Series C financing. [More]
Cypher Genomics, Sequenom sign development agreement for noninvasive prenatal tests

Cypher Genomics, Sequenom sign development agreement for noninvasive prenatal tests

Cypher Genomics, Inc., the leading genome informatics company, and Sequenom, Inc., the leading molecular diagnostics company, today announced a development agreement for next generation noninvasive prenatal tests (NIPT). [More]
Heptares Therapeutics, AstraZeneca report significant progress in drug discovery collaboration

Heptares Therapeutics, AstraZeneca report significant progress in drug discovery collaboration

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, announces significant progress in its drug discovery collaboration with AstraZeneca. [More]
Astute Medical, bioMérieux sign agreement to develop NephroCheck Test for acute kidney injury

Astute Medical, bioMérieux sign agreement to develop NephroCheck Test for acute kidney injury

bioMérieux, a world leader in the field of in vitro diagnostics, and Astute Medical, Inc., a company dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers, today announced that they have signed a global, semi-exclusive agreement regarding the development of a test for the early risk assessment of acute kidney injury (AKI). [More]
Medifast recognized as a 2015 Future 50 Blue Chip company by SmartCEO magazine

Medifast recognized as a 2015 Future 50 Blue Chip company by SmartCEO magazine

Medifast, Inc., a leading United States manufacturer and provider of clinically proven, weight-loss and healthy living products and programs is proud to be recognized by SmartCEO magazine as a 2015 Future 50 Blue Chip company for the fourth consecutive year. [More]

Nortek announces acquisition of Anthro

Nortek, Inc., a global diversified industrial company with leading brands and innovative air management and technology-driven products and solutions for residential and commercial applications, today announced it has acquired Anthro Corporation, a designer and manufacturer of technology furniture. [More]
Penn, Spark Therapeutics expand strategic relationship to develop treatment for progressive blindness

Penn, Spark Therapeutics expand strategic relationship to develop treatment for progressive blindness

The University of Pennsylvania has announced an expanded relationship with Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating, genetic diseases. [More]